Signal Genetics Gains CLIA Lab, Broadens Test Menu in $13.3M DiagnoCure Deal

Signal Genetics has gained DiagnoCure's US CLIA -compliant service laboratory and was granted a worldwide exclusive license to its Previstage GCC Colorectal Cancer Staging Test.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.